In a paper recently published in the Journal of Infectious Diseases, researchers examined the effect of vaginal tenofovir 1 percent gel use on the risk of acquiring herpes simplex virus type 2, or HSV-2. The study was conducted ...
Mar 1, 2019
1
139
It's often said that the HIV/AIDS epidemic has a woman's face. The proportion of women infected with HIV has been on the rise for a decade; in sub-Saharan Africa, women constitute 60 percent of people living with disease. ...
Sep 27, 2013
3
0
(Medical Xpress) -- Tenofovir, one of the most effective and commonly prescribed antiretroviral medications for HIV/AIDS, is associated with a significant risk of kidney damage and chronic kidney disease that increases over ...
Feb 13, 2012
0
0
(HealthDay)—A drug applied as a vaginal gel may substantially cut women's risk of contracting genital herpes, a common and incurable sexually transmitted infection.
Aug 6, 2015
2
76
Researchers at Kaiser Permanente Southern California, Pasadena, have found that in patients taking pre-exposure prophylaxis (PrEP), tenofovir alafenamide fumarate (TAF) use associated with higher incidents of hypertension ...
A new once-daily pill combining three antiretrovirals and a booster molecule is a safe and effective alternative to two widely used drug regimens for newly diagnosed HIV-positive adults who have had no previous treatment. ...
Jun 28, 2012
0
0
Determining whether a promising HIV prevention gel is safe for women to use while they are pregnant or breastfeeding is the aim of a new clinical trial being conducted by the National Institutes of Health-funded Microbicide ...
Jun 20, 2011
0
0
Heterosexuals who take daily AIDS drugs reduce the risk of being infected by the human immunodeficiency virus (HIV) by nearly two-thirds, ground-breaking studies said on Wednesday.
Jul 13, 2011
0
0
A first-of-its-kind study identifies mechanisms that explain how a drug commonly used to treat HIV and hepatitis causes kidney disease and kidney injury. The study is published ahead of print in Function.
Jan 17, 2023
0
19
In a major setback for AIDS prevention research, a clinical trial of a new vaginal gel supposed to reduce HIV infections has been suspended after studies showed it to be ineffective.
Nov 27, 2011
2
0
